Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
Study NCT ID:
NCT06810050
Status:
RECRUITING
Last Update Posted:
2025-02-05
First Post:
2025-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Sponsor:
CAGE Bio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-23
First Submit QC Date:
None
Study First Post Date:
2025-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-30
Last Update Post Date:
2025-02-05
Last Update Post Date Type:
ACTUAL